FDA Drug Recalls

Recalls / Class II

Class IID-0346-2017

Product

Chorionic Gonadotropin (New York State), 11,000 unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

Affected lot / code info
All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry. Known kit lot code: 06072016@44, 07292016@92, 08092016@80, 09132016@33. Known vial lot code: 04042016@30, 07222016@26, 04042016@30, 08252016@3

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Wells Pharmacy Network LLC
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
1210 SW 33rd Ave, N/A, Ocala, Florida 34474-2853

Distribution

Quantity
18 kits (number of vials per kit vary by prescription)
Distribution pattern
Nationwide

Timeline

Recall initiated
2016-09-21
FDA classified
2017-01-04
Posted by FDA
2017-01-11
Terminated
2021-07-02
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0346-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls